The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.
展开▼
机译：本发明涉及睾丸癌的体外诊断或预后的方法，其包括从选自SEQ ID NO：1中鉴定的序列中选择的至少一种核酸序列的存在或不存在至少一种表达产物的步骤。 图6或从将至少99％同一性的序列与SEQ ID NO：1至6中鉴定的序列中的一个序列表现出至少99％的序列，并将其用作睾丸癌标记物。
展开▼
